Clinical & Molecular Biomedicine (CMB) publishes innovative research that advances understanding of disease mechanisms and clinical interventions. The primary aim of CMB is to publish studies that explain the molecular mechanisms underlying human diseases and translate these findings into clinically meaningful outcomes. The journal welcomes interdisciplinary studies combining experimental, computational, and clinical research approaches.

Major Research Themes:

Genomics and Epigenetics

Identification of disease-associated genetic variants and epigenetic modifications.

Proteomics and Metabolomics

Discovery of molecular biomarkers and metabolic pathways associated with disease.

Translational Oncology

Research focusing on cancer biomarkers, molecular diagnostics, and targeted therapies.

Molecular Neurobiology

Studies investigating molecular mechanisms of neurological disorders.

Biomarker Discovery

Identification and validation of diagnostic, prognostic, and therapeutic biomarkers.

Drug Target Discovery

Research identifying novel molecular targets for therapeutic intervention.

Precision Medicine

Integration of molecular data for personalized therapeutic strategies.

Article Types:

The journal accepts several categories of manuscripts.

Original Research Articles

Full-length reports describing novel experimental or clinical findings.

Review Articles

Comprehensive and critical reviews summarizing current knowledge in a specific field.

Short Communications

Brief reports presenting important preliminary findings.

Case Reports

Clinical observations offering novel insights into disease or treatment.

Methods and Protocols

Descriptions of new techniques or improved experimental methodologies.

Letters to the Editor

Comments or discussions related to previously published articles.